YU22102A - Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja - Google Patents
Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenjaInfo
- Publication number
- YU22102A YU22102A YU22102A YUP22102A YU22102A YU 22102 A YU22102 A YU 22102A YU 22102 A YU22102 A YU 22102A YU P22102 A YUP22102 A YU P22102A YU 22102 A YU22102 A YU 22102A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- production
- components
- pharmaceutical agents
- agents containing
- new pyrimidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Jedinjenja formule (i) u kojima R1 predstavlja supstituisani ili nesupstituisani fenoksi, feniltio, fenilsulfinil, fenilsulfonil, fenilamino ili fenilmetil ostatak, a R2 predstavlja proizvoljno supstituisani aril ili heteroaril ostatak, sa aktivnošću inhibitora metaloproteinaze.[Compounds of formula (I) in which R1 represents a substituted or unsubstituted phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl, phenylamino or phenylmethyl residue, and R2 represents an optionally substituted aryl or heteroaryl residue, with metallo-proteinase inhibitor activity.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99119506 | 1999-10-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU22102A true YU22102A (sh) | 2004-11-25 |
Family
ID=8239103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU22102A YU22102A (sh) | 1999-10-01 | 2000-09-29 | Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja |
Country Status (29)
Country | Link |
---|---|
US (1) | US6498252B1 (sh) |
EP (1) | EP1226128B1 (sh) |
JP (1) | JP3848160B2 (sh) |
KR (1) | KR100459975B1 (sh) |
CN (1) | CN1157382C (sh) |
AR (1) | AR033651A1 (sh) |
AT (1) | ATE289595T1 (sh) |
AU (1) | AU768309B2 (sh) |
BR (1) | BR0014678A (sh) |
CA (1) | CA2385863C (sh) |
CO (1) | CO5210860A1 (sh) |
CZ (1) | CZ20021535A3 (sh) |
DE (1) | DE60018301T2 (sh) |
ES (1) | ES2235955T3 (sh) |
HK (1) | HK1050198A1 (sh) |
HU (1) | HUP0202832A3 (sh) |
IL (1) | IL148573A0 (sh) |
MA (1) | MA26823A1 (sh) |
MX (1) | MXPA02003192A (sh) |
NO (1) | NO20021380D0 (sh) |
NZ (1) | NZ517635A (sh) |
PE (1) | PE20010659A1 (sh) |
PL (1) | PL202680B1 (sh) |
RU (1) | RU2248971C2 (sh) |
TR (1) | TR200200858T2 (sh) |
UY (1) | UY26362A1 (sh) |
WO (1) | WO2001025217A1 (sh) |
YU (1) | YU22102A (sh) |
ZA (1) | ZA200201754B (sh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6716845B2 (en) * | 2001-03-30 | 2004-04-06 | Hoffmann-La Roche Inc. | Barbituric acid derivatives |
AU2002346729A1 (en) | 2001-12-20 | 2003-07-09 | Bristol-Myers Squibb Company | Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases |
WO2004084903A1 (en) * | 2003-03-27 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment and prevention of ocular pathologic angiogenesis |
WO2004084902A1 (en) * | 2003-03-28 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment of chronic wounds |
EP1737464B1 (en) * | 2004-04-01 | 2008-07-23 | F. Hoffmann-La Roche AG | Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
CN1950110B (zh) | 2004-04-01 | 2012-11-21 | 列日大学 | 嘧啶-2,4,6-三酮的药物组合物 |
EP1632489A1 (en) * | 2004-08-24 | 2006-03-08 | University of Liege | 5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use. |
RU2449994C1 (ru) * | 2011-03-10 | 2012-05-10 | Светлана Алексеевна Мещерякова | 6-(4-бензилпиперазино)-1,3-диметилурацила дигидрохлорид, проявляющий биологическую активность |
RU2598607C1 (ru) * | 2015-07-16 | 2016-09-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный университет" (Астраханский государственный университет) | Способ получения 5-гетарилметиленпиримидин-2,4,6-трионов |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1246743B (de) * | 1965-01-12 | 1967-08-10 | Dresden Arzneimittel | Verfahren zur Herstellung von 5-Phenyl-5-piperidinobarbitursaeuren |
US4595700A (en) | 1984-12-21 | 1986-06-17 | G. D. Searle & Co. | Thiol based collagenase inhibitors |
GB8726714D0 (en) | 1987-11-14 | 1987-12-16 | Beecham Group Plc | Compounds |
GB8827305D0 (en) | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
US5239078A (en) | 1990-11-21 | 1993-08-24 | Glycomed Incorporated | Matrix metalloprotease inhibitors |
AU652793B2 (en) | 1990-12-03 | 1994-09-08 | Celltech Limited | Peptidyl derivatives |
CA2058797A1 (en) | 1991-02-01 | 1992-08-02 | Michael John Broadhurst | Amino acid derivatives |
US5789434A (en) | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
TR199800990T2 (xx) | 1995-12-08 | 1998-07-21 | Agouron Pharmaceuticals, Inc. | Metaloproteinaz inhibit�rleri, bunlar� i�eren farmas�tik bile�imler, bunlar�n farmas�tik kullan�mlar� ve bunlar�n �retiminde kullan�labilecek y�ntemler ve ara �r�nler. |
DE19548624A1 (de) | 1995-12-23 | 1997-06-26 | Boehringer Mannheim Gmbh | Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
-
2000
- 2000-09-27 PE PE2000001013A patent/PE20010659A1/es not_active Application Discontinuation
- 2000-09-27 AR ARP000105063A patent/AR033651A1/es not_active Application Discontinuation
- 2000-09-27 CO CO00073355A patent/CO5210860A1/es not_active Application Discontinuation
- 2000-09-29 US US09/675,935 patent/US6498252B1/en not_active Expired - Fee Related
- 2000-09-29 WO PCT/EP2000/009535 patent/WO2001025217A1/en active IP Right Grant
- 2000-09-29 BR BR0014678-1A patent/BR0014678A/pt not_active Application Discontinuation
- 2000-09-29 UY UY26362A patent/UY26362A1/es not_active Application Discontinuation
- 2000-09-29 AT AT00967823T patent/ATE289595T1/de not_active IP Right Cessation
- 2000-09-29 TR TR2002/00858T patent/TR200200858T2/xx unknown
- 2000-09-29 KR KR10-2002-7003979A patent/KR100459975B1/ko not_active IP Right Cessation
- 2000-09-29 IL IL14857300A patent/IL148573A0/xx unknown
- 2000-09-29 PL PL357385A patent/PL202680B1/pl not_active IP Right Cessation
- 2000-09-29 CZ CZ20021535A patent/CZ20021535A3/cs unknown
- 2000-09-29 NZ NZ517635A patent/NZ517635A/en unknown
- 2000-09-29 YU YU22102A patent/YU22102A/sh unknown
- 2000-09-29 CA CA002385863A patent/CA2385863C/en not_active Expired - Fee Related
- 2000-09-29 MX MXPA02003192A patent/MXPA02003192A/es active IP Right Grant
- 2000-09-29 HU HU0202832A patent/HUP0202832A3/hu unknown
- 2000-09-29 EP EP00967823A patent/EP1226128B1/en not_active Expired - Lifetime
- 2000-09-29 JP JP2001528163A patent/JP3848160B2/ja not_active Expired - Fee Related
- 2000-09-29 RU RU2002110106/04A patent/RU2248971C2/ru not_active IP Right Cessation
- 2000-09-29 CN CNB00813006XA patent/CN1157382C/zh not_active Expired - Fee Related
- 2000-09-29 AU AU77849/00A patent/AU768309B2/en not_active Ceased
- 2000-09-29 DE DE60018301T patent/DE60018301T2/de not_active Expired - Lifetime
- 2000-09-29 ES ES00967823T patent/ES2235955T3/es not_active Expired - Lifetime
-
2002
- 2002-03-01 ZA ZA200201754A patent/ZA200201754B/en unknown
- 2002-03-20 NO NO20021380A patent/NO20021380D0/no not_active Application Discontinuation
- 2002-04-01 MA MA26578A patent/MA26823A1/fr unknown
-
2003
- 2003-04-03 HK HK03102405A patent/HK1050198A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1221439A4 (en) | TETRAHYDROQUINOLINE DERIVATIVES | |
MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
AP9901442A0 (en) | 4-(2-Keto-1-benzimidazolinyl) piperidine compounds as orl1-receptor agonists. | |
DK0911333T3 (da) | Pyrazol [4,3-d]pyrimidinderivater og farmaceutiske præparater, der indeholder disse | |
AU674477B2 (en) | Heterocyclic-cyclic amine derivatives | |
WO1997030677A3 (en) | Pentafluorobenzenesulfonamides and analogs | |
IL94915A (en) | Substituted quinazolinones and pharmaceutical compositions containing them | |
WO1999064409A3 (de) | Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
BG103268A (en) | Propionic acid derivatives and their application | |
ES2053609T3 (es) | Derivados de urea inhibidores de lipoxigenasa. | |
CA2379026A1 (en) | Substituted thiene-3-yl-sulphonylamino(thio)carbonyl-triazolin(thi)ones | |
EA200200510A1 (ru) | 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр | |
NZ233735A (en) | Heterocyclic substituted aminophenol derivatives | |
TR200000586T2 (tr) | Farmasötik maddelerin oral yoldan biyolojik kullanışlılığının arttırılması için bir yöntem, bileşimler ve kitler. | |
AU6617596A (en) | Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them | |
YU22102A (sh) | Novi pirimidin 2,4,6-trion derivati, postupci za njihovu proizvodnju i farmaceutska sredstva koja sadrže ova jedinjenja | |
WO2000016763A3 (en) | Antimalarial agents | |
BG104712A (en) | S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds | |
BG104447A (en) | Biphenylamidine derivatives | |
TR200201128T2 (tr) | PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri. | |
IL138688A0 (en) | Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme | |
DE60036558D1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
WO2003080631A8 (en) | Plasma carboxypeptidase b inhibitors | |
ES2192789T3 (es) | Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios. | |
HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives |